ATM is phosphorylated and active during both hypoxia and reoxygenation. GM0536 cells were exposed to the levels of hypoxia shown, to hypoxia-mimetic CoCl2 for 6 h, or, as a positive control, to the DNA-damaging agent NCS (5 ng/ml) for 10 min. Shown is a Western blot for the proteins or protein modifications indicated. (A) GAPDH is shown as a loading control. (B) HCT116wt and HCT116HIF-1α−/− cells were exposed to hypoxia (Hyp) for 16 h or NCS for 2 h. Western blotting was carried out for the proteins indicated. (C) The GM0536 cell line was exposed to hypoxia as shown and then reoxygenated for the time periods indicated. The levels of phosphorylated and total ATM are shown. (D) LCLs from either a healthy control (GM0536) or an AT patient (GM1526) were exposed to hypoxia for the times indicated, and Western blotting was carried out for Kap1-S824, DNA-PKcs-T2609, and GAPDH as a loading control. (E) GM0536 cells were exposed to hypoxia for 8 h in the presence of the ATM inhibitor (ATMi) (10 μM). Cells were also treated with NCS for 10 min as a positive control. The levels of phosphorylated Kap1 (residue serine 824) are shown. wt, wild type; N, normoxic.